Compare RCAT & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCAT | BHC |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2017 | 1996 |
| Metric | RCAT | BHC |
|---|---|---|
| Price | $11.17 | $5.06 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $20.00 | $8.00 |
| AVG Volume (30 Days) | ★ 16.2M | 1.8M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ N/A | N/A |
| Revenue | $17,836,382.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $271.60 | $4.61 |
| Revenue Next Year | $41.21 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 79.95 | N/A |
| 52 Week Low | $5.77 | $4.93 |
| 52 Week High | $18.78 | $8.69 |
| Indicator | RCAT | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 46.58 | 40.42 |
| Support Level | $10.52 | $4.93 |
| Resistance Level | $13.19 | $6.31 |
| Average True Range (ATR) | 1.51 | 0.21 |
| MACD | -0.14 | -0.01 |
| Stochastic Oscillator | 26.92 | 17.20 |
Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.